Plain-English translation of NCT05978141 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research registry—a database—for people with T-cell lymphoma, a rare blood cancer that affects infection-fighting cells. Researchers at Memorial Sloan Kettering are collecting medical information and tumor tissue samples from patients to learn more about how these diseases develop and progress. By joining, you'd help doctors understand these cancers better and develop better treatments for future patients.
T-cell lymphomas are rare and complex, and doctors still have much to learn about them. This registry will gather information and tumor samples in one place so researchers can study patterns, understand what makes each person's cancer unique, and ultimately find better ways to treat the disease.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow researchers to collect and store your medical information and tumor tissue samples in a central database. You would need to consent to sharing your existing biopsy samples or agreeing to provide a fresh biopsy if needed. Beyond that, the study involves ongoing clinical follow-up with your regular doctor—you're not required to visit Memorial Sloan Kettering specifically, and participation doesn't prevent you from enrolling in other clinical trials.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States